(Q37930475)

25 August 2017

1 reference

title

Systemic lupus erythematosus, the brain, and anti-NR2 antibodies (English)

1 reference

systemic lupus erythematosus

25 August 2017

1 reference

0 references

Maria B Lauvsnes

1

0 references

author name string

Roald Omdal

series ordinal

2

1 reference

25 August 2017

10 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

259

1 reference

25 August 2017

4

1 reference

25 August 2017

622-629

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-011-6232-5

25 August 2017

0 references

cites work

The blood-brain barrier in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Cognitive impairment in systemic lupus erythematosus: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Plasticity in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

A revised estimate of twin concordance in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Immunity and behavior: antibodies alter emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Cognition and immunity; antibody impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuropsychological patterns in systemic lupus erythematosus patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Glutamate receptors, neurotoxicity and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Glutamate receptors in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Ligand-gated ion channel interactions with cytoskeletal and signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Interferon-alpha in lupus psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

The stressed CNS: when glucocorticoids aggravate inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6232-5

Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

1 reference

12 December 2020

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

1 reference

12 December 2020

Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons

1 reference

12 December 2020

Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats

1 reference

12 December 2020

Prevalence of cognitive impairment in systemic lupus erythematosus.

1 reference

12 December 2020

Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.

1 reference

12 December 2020

Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors

1 reference

12 December 2020

Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus.

1 reference

12 December 2020

Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests

1 reference

12 December 2020

The neurological manifestations of systemic lupus erythematosus

1 reference

12 December 2020

Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.

1 reference

12 December 2020

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

12 December 2020

Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction

1 reference

12 December 2020

A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow

1 reference

12 December 2020

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis

1 reference

12 December 2020

Brain pathology in systemic lupus erythematosus

1 reference

12 December 2020

Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives

1 reference

12 December 2020

Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.

1 reference

12 December 2020

10.1007/S00415-011-6232-5

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21909801